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The study subjects varied widely in age,
height, and weight. To compensate for this
variability, Swan et al. (2005) defined a new
parameter, which they termed the “anogeni-
tal index” (AGI), by dividing AGD by body
weight. In the absence of validation, the sig-
nificance of the AGI is not known, and vari-
ation cannot be assumed to be related to
hormonal exposure. Swan et al. suggested
that the AGI is proportional to the normal
genital development of male infants, but
they provided no supporting evidence. Also,
much scatter can be seen in the plot of
“AGI by boy’s age” (Figure 1; Swan et al.
2005). Salazar-Martinez et al. (2004) found
that, in male infants,AGD correlated best
with length, not weight.
Per definition, the AGD represents a
one-dimensional parameter of the human
anatomy. In analogy to similar anatomic
parameters (e.g., length of limbs, hands, or
feet), the AGD is likely to be proportional
to body length and not to body weight.
Therefore, Swan et al.’s use of the (body
weight-related) AGI in the study has little
biologic plausibility and appears to be arbi-
trary.
Swan et al. (2005) did not normalize
maternal phthalate urinary concentrations
for urine volume. This leaves open the pos-
sibility that higher urinary phthalate con-
centrations in individuals may have been
due to lower urinary volume rather that
higher phthalate exposure, and casts doubt
on the maternal exposure classification cate-
gories. Phthalate levels were based on only a
single sample per individual, and fetal devel-
opment at the time of urine sampling was
not reported.
Numerous maternal factors (alcohol
consumption, medication, profession, body
mass) may affect fetal development.
Although it is unknown what factors, if any,
would influence AGD in human infants, in
the absence of these data, confounding fac-
tors cannot be excluded.
The levels of phthalates Swan et al.
(2005) reported in maternal urine samples
are extremely low, and the corresponding
exposures are many orders of magnitude
lower than the exposures at which selected
phthalates have been found to have adverse
reproductive effects in rodents. For exam-
ple, assuming excretion of 2 L of urine/day,
the reported concentration of butyl benzyl
phthalate corresponds to an exposure of
approximately 60 µg/day, or 1 µg/kg/day
for a woman weighing 60 kg. Butyl benzyl
phthalate has been shown to have only
slight, hormone-like effects in rats at doses
of ≥ 100 mg/kg/day (Nagao et al. 2000), or
~ 100,000-fold higher than the levels seen
by Swan et al. (2005). In the case of the
metabolite monoethyl phthalate, the expo-
sure level for the corresponding parent com-
pound diethyl phthalate was on the order of
1,000,000-fold lower than a level found to
have no adverse reproductive effects in rats
(4,000 mg/kg/day, the highest dose tested)
(Scientific Committee on Cosmetic
Products and Non-food Products 2002). It
is biologically and toxicologically inconceiv-
able that such low levels of human exposure
would produce the significant structural dif-
ferences claimed by Swan et al. (2005). 
In summary, the relevance of AGD as
an end point of interest in humans is
entirely speculative, and the correlation
reported by Swan et al. (2005) is lacking in
biologic plausibility and remains unproven.
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Anogenital Distance and
Phthalate Exposure: Swan
et al. Respond
In their letter, McEwen and Renner raise
several points that we would like to discuss. 
First, because all infants in our study
(Swan et al. 2005) appeared normal,
McEwen and Renner infer that there is no
evidence of an adverse effect. However, the
absence of evidence of an effect in infancy
does not preclude serious adverse effects in
later life. For example, the genital cancers
that were identified in young women, on
average 19 years after their prenatal expo-
sure to the drug diethylstilbestrol, were seen
in females who had appeared to be com-
pletely normal until that time (Herbst et al.
1971). In this case, unlike that example, we
do have some evidence of anatomical
changes in young boys. Although anogenital
distance (AGD) has rarely been used as a
measure of androgen action in humans, our
data suggest that shortened AGD reflects
reduced androgen action in utero; AGD was
correlated with the degree of testicular
descent and penile volume, and children
with smaller AGD tended to have smaller
scrotums; these are all signs of reduced
androgen action. 
McEwen and Renner state that the
range of AGD reported in our study (Swan
et al. 2005) is likely to be representative of
normal study subjects. In fact, this informa-
tion is not yet available because this is the
first population-based study that utilized
this measurement. AGD has, however, been
used in the diagnosis of medical conditions
such as congenital adrenal hyperplasia, in
which AGD in females is increased by
excess androgen exposure (Callegari et al.
1987). AGD is also known to be sexually
dimorphic in humans as well as rodents
(Salazar-Martinez et al. 2004).
McEwen and Renner point out that one
previous study [n = 42; (Salazar-Martinez
et al. 2004)] used an alternative measure of
AGD in human infants. However, as we
indicated in our article (Swan et al. 2005),
this alternative definition is less precise than
the one we used and does not correspond to
the measure of anogenital distance most fre-
quently used in toxicologic studies of
rodents. Our use of this measure of AGD
emphasizes the correspondence between tra-
ditional toxicology studies and our study. 
In our study (Swan et al. 2005) we did
not have data that would allow us to con-
sider parental phenotype (e.g. parental
height or father’s AGD), as McEwen and
Renner suggest should be done. If AGD was
affected by parental stature (through infant
body size), this association should be con-
trolled for by adjusting for body size.
Moreover, in order for a phenotypic variable
to explain the observed association, it too
would have to be related to maternal phtha-
late levels. This, too, would be an interest-
ing finding. 
McEwen and Renner question the use
of normalizing AGD by dividing by weight
(AGI) at examination. We examined several
alternative measures of body size and, as dis-
cussed in our article (Swan et al. 2005), AGI
provided the best fit to the data (independent
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of phthalates). Vanderbergh and Huggett
(1995) found the same to be true in rodents.
The fact that there was some variation of
AGI with age is to be expected; not all
1-year-olds have the same length, either. 
McEwen and Renner point out potential
sources of “exposure misclassification”
which, we agree, may have been present (and
we stated so) (Swan et al. 2005). However,
unless these sources of measurement error
were related to AGD, their presence would
lead to underestimates of the strength of the
associations we presented. 
We examined a number of potential
confounders, such as maternal smoking and
alcohol consumption; the prevalence of both
was quite low (Swan et al. 2005). None
affected results appreciably. Of course, the
phantom “unmeasured confounder” always
lurks in the wings of any observational
study, can never be ruled out, and is a
favorite of critics of epidemiologic studies.
Any constructive suggestions for alternatives
to observational studies would be appreci-
ated; the only alternative we know of, ran-
domizing pregnant women to receive
phthalates (or not), hardly seems ethical.
Rodent studies test only one phthalate at
a time. As we demonstrated (Swan et al.
2005), women were exposed to measurable
levels of multiple phthalates, many known to
be reproductively toxic. Until we have data
on the toxicology of this complex mixture,
we do not have the information to draw
conclusions about the relative toxicity of
these compounds in rodents versus humans.
Furthermore, although doses in rodent stud-
ies of specific phthalates are high, effects
have been demonstrated at lower doses used
in recent studies (Lehmann et al.).
Unfortunately no toxicologic study has yet
examined effects of phthalates at environ-
mental levels. Because we did find a signifi-
cant association with phthalates at such
levels, we can only conclude that environ-
mental levels, however low, are associated
with somatic alterations in humans. 
Our study (Swan et al. 2005) is rela-
tively small and must be replicated; subse-
quent studies will undoubtedly eliminate
many of the sources of potential exposure
and outcome misclassification. Nonetheless,
in this first study of its kind, we set out to
test the hypothesis, suggested by a large tox-
icologic literature (Gray et al. 2000), that
prenatal phthalate exposure is associated
with several measures in humans that reflect
the antiandrogenic action of these chemi-
cals. Using similar outcome measures to
those utilized in these toxicologic studies,
that is what we found. 
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ERRATA
In the October articles “Children’s Centers
Study Kids and Chemicals” [Environ
Health Perspect 113:A664–A668 (2005)]
and “Are EDCs Blurring Issues of
Gender?” [Environ Health Perspect
113:A670–A677 (2005)], photographs
and their captions erroneously imply that
plastic drink bottles contain ortho-phtha-
lates. Plastic drink bottles sold in the
United States are made from polyethylene
terephthalate and do not contain ortho-
phthalates. Also, at the end of the EDCs
article, references are made to plastic wrap
and Saran Wrap. For clarification, neither
plastic wrap nor Saran Wrap contains
ortho-phthalates. EHP regrets these errors.
EHP regrets the incorrect and uninten-
tional inference in “Paving Paradise: The
Peril of Impervious Surfaces” [Environ
Health Perspect 113:A456–A462 (2005)]
that coal tar pitch is used in the actual
hot-mix asphalt used to pave roads. Coal
tar pitch is instead used in many sealcoat
formulations used atop asphalt pavement.
Findings published in the 1 August 2005
issue of Environmental Science &
Technology suggest, in fact, that coal tar-
based parking lot sealant may be a major
contributor to stream loads of polycyclic
aromatic hydrocarbons, including many
known carcinogens.
In Figure 1 of the article by Chen et al.
[Environ Health Perspect 113:1723–1729
(2005)], the legend should have read
(A) PM10; (B) PM2.5, instead of (A) PM2.5;
(B) PM10.
In Figure 1 of the article by Tsan et al.
[Environ Health Perspect 113:1784–1786
(2005)], the double bond between HN
and boron was incorrect. The corrected
figure appears below.
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